PI
REPL icon

Pennant Investors’s Replimune Group REPL Stock Holding History

Pennant Investors’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-30,500
Closed -$275K – 40
2024
Q2 		$275K Hold
30,500
– – 0.07% 34
2024
Q1 		$249K Hold
30,500
– – 0.06% 38
2023
Q4 		$257K Buy
+30,500
New +$354K 0.06% 39

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pennant Investors's REPL Position: Q3 2024 in Review

Pennant Investors sold out of Replimune Group (REPL) in Q3 2024, closing a stake of 30,500 shares — an estimated $275K sold.

Pennant Investors first reported a position in REPL in Q4 2023 and held it in 3 quarters. The position peaked at $275K in Q2 2024. 144 funds tracked by Wall St. Rank hold REPL as of Q3 2024.

  • Pennant Investors reported no remaining Replimune Group position as of Q3 2024 after selling out during the quarter.
  • Pennant Investors sold 30,500 Replimune Group shares in Q3 2024, an estimated $275K.
  • Pennant Investors first reported a position in Replimune Group in Q4 2023 and held it in 3 quarters.
  • Pennant Investors's Replimune Group position peaked at $275K in Q2 2024.
  • 144 funds tracked by Wall St. Rank held Replimune Group as of Q3 2024.

Based on Pennant Investors's 13F filing for Q3 2024, filed 14 Nov 2024.